Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FC25N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,752
Award facts
- Contract value 100% obligated
- $33,752.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33.8K delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on June 18, 2025, with a completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The award reflects the company's role as a critical pharmaceutical distributor for federal military and healthcare supply chains, specifically supporting the delivery of specialty medications to military health systems.
This delivery order is issued under AmerisourceBergen's SPE2DX indefinite delivery contract with DLA valued at $999.9M through December 2026, which serves as the primary vehicle for global pharmaceutical support to military healthcare programs. Dupixent, a biologic medication used to treat conditions including atopic dermatitis, asthma, and eosinophilic conditions, represents the type of specialty pharmaceutical product routinely procured through the DLA's medical supply chain to support service members and military health system beneficiaries. The contract to be performed from AmerisourceBergen's Conshohocken, Pennsylvania facility reflects the company's established capacity to fulfill urgent federal medical supply requirements with minimal fulfillment timelines.
Quick answers
Who was awarded contract SPE2DB25FC25N?
SPE2DB25FC25N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FC25N worth?
The government has obligated $33,752 on SPE2DB25FC25N.
Is contract SPE2DB25FC25N an order under another contract?
Yes. SPE2DB25FC25N is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC25N competed?
The extent of competition for SPE2DB25FC25N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award